Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaJames R. Cerhan, Corinne Haïoun, Sonja I. Berndt et al.|Nature Genetics|2014Cited by 175
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL studyFranck Morschhauser, Loretta J. Nastoupil, Koji Izutsu et al.|Nature Medicine|2024Cited by 127
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centersCédric Rossi, Hervé Ghesquières|American Journal of Hematology|2018Cited by 120
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohortHervé Ghesquières, Alain Monnereau|BMC Public Health|2021Cited by 17